Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Just weeks after announcing a deal to sell its antibiotics manufacturing in the U.S. to Neopharma, India’s Dr. Reddy’s Laboratories says it will now unload its API manufacturing business in Jeedimetla ...

The pharmaceutical CMO market thrives on increased outsourcing due to strategic realignment and advanced therapy approvals. Expanding in Asia-Pacific and integrated service offerings further drive ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Sigachi Industries introduces a new Cystic Fibrosis API combination, enhancing its strategic focus on complex specialty ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

Bristol-Myers Squibb (BMS) has agreed to sell its small-molecule active pharmaceutical ingredient (API) manufacturing facility in Swords, Ireland, to Seoul, South Korea-based contract development and ...

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...